Renaissance Technologies
OKUR icon

Renaissance Technologies’s OnKure Therapeutics OKUR Stock Holding History

Renaissance Technologies’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$962K Sell
353,150
-5,588
-2% -$21.1K ﹤0.01% 2343
2026
Q2 		$1.64M Sell
358,738
-18,512
-5% -$79.4K ﹤0.01% 2077
2026
Q1 		$1.56M Buy
377,250
+129,900
+53% +$401K ﹤0.01% 2022
2025
Q4 		$717K Buy
247,350
+71,600
+41% +$214K ﹤0.01% 2427
2025
Q3 		$483K Buy
175,750
+53,114
+43% +$132K ﹤0.01% 2810
2025
Q2 		$293K Buy
122,636
+80,773
+193% +$212K ﹤0.01% 3048
2025
Q1 		$180K Sell
41,863
-5,587
-12% -$31.4K ﹤0.01% 3096
2024
Q4 		$408K Sell
47,450
-2,703
-5% -$40.9K ﹤0.01% 2937
2024
Q3 		$853K Buy
50,153
+5,933
+13% +$87.8K ﹤0.01% 2542
2024
Q2 		$668K Sell
44,220
-15,110
-25% -$256K ﹤0.01% 2548
2024
Q1 		$985K Buy
59,330
+19,290
+48% +$318K ﹤0.01% 2496
2023
Q4 		$641K Buy
40,040
+36,440
+1,012% +$2.27M ﹤0.01% 2666
2023
Q3 		$274K Sell
3,600
-2,511
-41% -$171K ﹤0.01% 2974
2023
Q2 		$401K Buy
6,111
+3,551
+139% +$286K ﹤0.01% 2987
2023
Q1 		$153K Sell
2,560
-1,160
-31% -$42K ﹤0.01% 3367
2022
Q4 		$87K Sell
3,720
-580
-13% -$15.4K ﹤0.01% 3666
2022
Q3 		$144K Buy
4,300
+2,000
+87% +$65.7K ﹤0.01% 3490
2022
Q2 		$61K Buy
+2,300
New +$53.5K ﹤0.01% 3963

Other funds holding OKUR

Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Renaissance Technologies's OKUR Position: Q3 2026 in Review

Renaissance Technologies reduced its OnKure Therapeutics (OKUR) stake by 1.6% in Q3 2026, selling an estimated $21.1K and leaving 353,150 shares worth $962K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

Renaissance Technologies first reported a position in OKUR in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.64M in Q2 2026. 45 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

  • Renaissance Technologies held 353,150 shares of OnKure Therapeutics worth $962K as of Q3 2026.
  • Renaissance Technologies sold 5,588 OnKure Therapeutics shares in Q3 2026, an estimated $21.1K.
  • OnKure Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2343 holding.
  • Renaissance Technologies first reported a position in OnKure Therapeutics in Q2 2022 and has held it in 18 quarters since.
  • Renaissance Technologies's OnKure Therapeutics position peaked at $1.64M in Q2 2026.
  • 45 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.